Related Experiment Video
Updated: Jul 13, 2026
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
User satisfaction with fingerstick versus continuous glucose monitoring in surgical wards: A two-centre
Tine Lumbye Thomsen1, Marian Christin Petersen1,2, Line Abrahamsen3
1Department of Surgery, Zealand University Hospital, Koege, Denmark.
Aims:
To compare person-reported outcomes on point-of-care (POC) fingerstick glucose monitoring (FSGM) with POC continuous glucose monitoring systems (CGMS) in adults admitted to surgical wards. The primary outcome was convenience; the secondary outcome was satisfaction with diabetes-related treatment.
Methods:
This two-centre non-randomised clinical trial consisted of an initial standard care period with FSGM, followed by a period with POC CGMS. The trial included adults at risk of hypo- or hyperglycaemia in Danish surgical wards who were initially prescribed glucose monitoring at least four times daily and expected to be hospitalised for a minimum of three days. Person-reported outcomes were assessed at discharge using the validated Danish Diabetes Treatment Satisfaction Questionnaire for Inpatients (DTSQ-IP).
Results:
A total of 199 adults were included. Adjusted analyses showed significantly higher convenience (p < 0.0001) and overall satisfaction (p = 0.001) with POC CGMS than with FSGM. CGMS also produced significantly higher adjusted scores for flexibility, willingness to recommend and continue the treatment, quality of communication with staff, time spent with diabetes nurses and the discharge treatment plan. No between-group differences were found in experiences of hypoglycaemia, hyperglycaemia and glucose monitoring or satisfaction with understanding of the treatment, staff knowledge of participants' treatment or responsiveness to needs.
Conclusions:
Among adults at risk of hypo- or hyperglycaemia in surgical wards, CGMS as POC provided greater convenience and satisfaction than FSGM regardless of diabetes status, reflecting greater comfort with CGMS. No differences were found in user-reported dysglycaemia.
